Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT03088202
Eligibility Criteria:
Inclusion Criteria:
* A verified metastatic or locally advanced cancer of the upper GI tract, lower GI tract, pancreas, liver, breast, bladder, prostate, kidney, cholangiocarcinoma, or malignant melanoma
* Defined as a palliative care patient, with expected life expectancy of \<12 months
* Scheduled to start what is perceived as last line of chemotherapy (definition: tumor directed medical therapy)
o Observe: different time points for inclusion and line of treatment apply for the specific diagnoses
* Age \> 18 years
* Fluency in written and oral Norwegian
* Physically and cognitively able to provide written informed consent, based on clinical judgment
* Scheduled to receive all oncological and specialized palliative treatment at the participating hospital
* World Health Organization (WHO) performance status 0-2
Exclusion Criteria:
* Any serious psychiatric diagnosis (e.g. psychotic, bipolar disorder), substance abuse or cognitive impairment as judged by standard clinical criteria (disturbed consciousness, disorientation to time/place and attention deficits) at the discretion of the attending physician that precludes completion of PROs
* A cancer diagnosis other than the ones above
* Multiple malignancies
* Serious substance abuse
* Already included in a palliative care program
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03088202
Study Brief:
Protocol Section:
NCT03088202